A change in serum myoglobin to detect acute myocardial infarction in patients with normal troponin I levels.

We sought to determine the sensitivity of a change in myoglobin for acute myocardial infarction (AMI) in patients who had normal levels of troponin I at presentation. Myoglobin increases as soon as 1 to 2 hours after symptom onset in AMI. The change in myoglobin may help identify AMI in patients with normal cardiac levels of troponin I on admission. A total of 817 consecutive patients who were examined in the emergency department for possible AMI were studied. In patients whose electrocardiograms were nondiagnostic, we measured levels of myoglobin and cardiac troponin I at presentation, at 90 minutes, and at 3 and 9 hours. Patients whose initial levels of myoglobin (<200 ng/ml) and cardiac troponin I (<0.4 ng/ml) were normal underwent receiver-operating characteristic curve analysis to determine the best cutpoint for a myoglobin increase from 0 to 90 minutes. Overall, 75 patients (9%) were diagnosed with AMI, including 27 patients with normal cardiac levels of troponin I at presentation. An increase of 20 ng/ml of myoglobin from 0 to 90 minutes provided maximal diagnostic utility in patients who did not have increased levels of myoglobin or cardiac troponin I at presentation. In the absence of an increased level of cardiac troponin I or myoglobin at presentation in the emergency department, a change >or=20 ng/ml of myoglobin at 90 minutes produced 83.3% sensitivity, 88.6% specificity, and 99.5% negative predictive value for AMI. The combined sensitivity of levels of cardiac troponin I and myoglobin and a change >or=20 ng/ml of myoglobin over 90 minutes was 97.3%. In emergency department patients with normal cardiac levels of troponin I at presentation, a change in myoglobin provides a highly accurate diagnosis of AMI within 90 minutes.

[1]  James McCord,et al.  Ninety-Minute Exclusion of Acute Myocardial Infarction By Use of Quantitative Point-of-Care Testing of Myoglobin and Troponin I , 2001, Circulation.

[2]  R. Fitzgerald,et al.  Ninety-minute accelerated critical pathway for chest pain evaluation. , 2001, The American journal of cardiology.

[3]  M. Waterman,et al.  Detection of myoglobin by radioimmunoassay in human sera: Its usefulness and limitations as an emergency room screening test for acute myocardial infarction☆ , 1978 .

[4]  R. D. de Winter,et al.  Value of myoglobin, troponin T, and CK-MBmass in ruling out an acute myocardial infarction in the emergency room. , 1995, Circulation.

[5]  E. Antman,et al.  Very early risk stratification after thrombolytic therapy with a bedside myoglobin assay and the 12-lead electrocardiogram. , 2000, American heart journal.

[6]  Hugo A. Katus,et al.  Myocardial infarction redefined--a consensus document of The Joint European Society of Cardiology/American College of Cardiology Committee for the redefinition of myocardial infarction. , 2000, European heart journal.

[7]  E. Antman,et al.  The prognostic value of serum myoglobin in patients with non-ST-segment elevation acute coronary syndromes. Results from the TIMI 11B and TACTICS-TIMI 18 studies. , 2002, Journal of the American College of Cardiology.

[8]  D. Gornall,et al.  Serial myoglobin quantitation in the early assessment of myocardial damage: a clinical study. , 1996, Clinical biochemistry.

[9]  T. Kircher,et al.  Myoglobin in the early evaluation of acute chest pain. , 1995, American journal of clinical pathology.

[10]  J. Mair,et al.  Early diagnosis of acute myocardial infarction by a newly developed rapid immunoturbidimetric assay for myoglobin , 1992, British heart journal.

[11]  Carl J Pepine,et al.  ACC/AHA 2002 guideline update for the management of patients with unstable angina and non-ST-segment elevation myocardial infarction--summary article: a report of the American College of Cardiology/American Heart Association task force on practice guidelines (Committee on the Management of Patients , 2002, Journal of the American College of Cardiology.

[12]  R. Califf,et al.  Changing the diagnosis of acute myocardial infarction: implications for practice and clinical investigations. , 2002, American heart journal.

[13]  E. Cook,et al.  Value of additional two-hour myoglobin for the diagnosis of myocardial infarction in the emergency department. , 1999, The American journal of cardiology.

[14]  P. Clopton,et al.  A Prospective Study of an Algorithm Using Cardiac Troponin I and Myoglobin as Adjuncts in the Diagnosis of Acute Myocardial Infarction and Intermediate Coronary Syndromes in a Veteran's Hospital , 2000, Clinical cardiology.

[15]  K. Fox,et al.  Myocardial infarction redefined: the new ACC/ESC definition, based on cardiac troponin, increases the apparent incidence of infarction , 2002, Heart.

[16]  A. Jaffe,et al.  Bedside Multimarker Testing for Risk Stratification in Chest Pain Units: The Chest Pain Evaluation by Creatine Kinase-MB, Myoglobin, and Troponin I (CHECKMATE) Study , 2001 .

[17]  J. W. Schaeffer,et al.  ACC/AHA 2002 guideline update for the management of patients with unstable angina and non–ST-segment elevation myocardial infarction—summary article , 2002 .

[18]  R. Jesse,et al.  Use of the combination of myoglobin and CK-MB mass for the rapid diagnosis of acute myocardial infarction. , 1997, The American journal of emergency medicine.

[19]  C. Heusghem,et al.  Serum myoglobin determinations in the assessment of acute myocardial infarction. , 1982, European heart journal.

[20]  G. L. Higgins,et al.  A randomized trial of the effects of early cardiac serum marker availability on reperfusion therapy in patients with acute myocardial infarction: the serial markers, acute myocardial infarction and rapid treatment trial (SMARTT). , 2000, Journal of the American College of Cardiology.

[21]  R H Christenson,et al.  Simultaneous rapid measurement of whole blood myoglobin, creatine kinase MB, and cardiac troponin I by the triage cardiac panel for detection of myocardial infarction. , 1999, Clinical chemistry.